Actively Recruiting
Evaluating DefenCath Versus Heparin for Preventing Bloodstream Infections in Adults and Adolescents Receiving Total Parenteral Nutrition Through a Central Venous Catheter
Led by CorMedix Therapeutics · Updated on 2026-09-25
200
Participants Needed
24
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a Phase 3, randomized, double-blind, controlled study to evaluate the safety and effectiveness of DefenCath compared to heparin in preventing central line-associated bloodstream infections CLABSIs. The study includes adults and adolescents who receive home total parenteral nutrition TPN through a central venous catheter CVC. The trial aims to reduce the risk of bloodstream infections in this population by comparing two catheter lock solutions. Participants will be randomly assigned to receive either DefenCath or heparin as a catheter lock solution used for their central venous catheter. The treatments will be administered regularly as part of their ongoing TPN care, and the study will last up to 12 months. Both groups will be monitored under the same conditions to assess differences in infection rates and safety outcomes. During the study, participants or their caregivers will self-administer the catheter lock solution according to their usual TPN and line access schedule. They will also maintain a daily diary to record treatment adherence and any adverse events. Researchers will track the occurrence of bloodstream infections, safety events, laboratory results, vital signs, and physical exam findings throughout the 12-month period. This allows a comprehensive evaluation of both efficacy and safety over an extended time.
CONDITIONS
Brief Title
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults And Adolescent Participants Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
Research Team
L
Liz Hurlburt, Chief Clinical Strategy & Operations Officer
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here